Dan Loeb increased its stake in Monsanto Co New (MON) by 85% based on its latest 2016Q3 regulatory filing with the SEC. Third Point Llc bought 1.70 million shares as the company’s stock rose 0.87% with the market. The hedge fund run by Dan Loeb held 3.70 million shares of the agricultural chemicals company at the end of 2016Q3, valued at $378.14M, up from 2.00M at the end of the previous reported quarter. Third Point Llc who had been investing in Monsanto Co New for a number of months, seems to be bullish on the $47.12B market cap company. The stock is down 0.45% or $0.49 hitting $107.95, despite the positive news. About 640,108 shares traded hands. Monsanto Company (NYSE:MON) has risen 0.97% since June 7, 2016 and is uptrending. It has underperformed by 6.45% the S&P500.
Third Point Llc, which manages about $17.97 billion and $11.50B US Long portfolio, decreased its stake in Mohawk Inds Inc (NYSE:MHK) by 600,000 shares to 900,000 shares, valued at $180.31M in 2016Q3, according to the filing. It also reduced its holding in Yum Brands Inc (NYSE:YUM) by 2.00M shares in the quarter, leaving it with 500,000 shares, and cut its stake in Union Pac Corp (NYSE:UNP).
Daniel Loeb is one of the original pioneers of activist investing and is known to be very outspoken. He has achieved amazing returns, including 150 million dollars in 2005, 200 million dollars in 2006 and an amazing 270 million dollars in 2007. As of 2010, Third Point’s flagship fund gained 41.7%. Third Point Llc is a New York-based hedge fund that was founded by Dan Loeb. It had more than $17.97 billion assets under management in November, 2014. Taken from Third Point latest Adv, the fund reported to have 60 full and part-time employees. Among which 26 performing investment advisory and research functions. The hedge fund had between 11-25 clients.
Insitutional Activity: The institutional sentiment increased to 1.02 in 2016 Q3. Its up 0.11, from 0.91 in 2016Q2. The ratio is positive, as 81 funds sold all MON shares owned while 303 reduced positions. 98 funds bought stakes while 293 increased positions. They now own 317.45 million shares or 6.24% less from 338.57 million shares in 2016Q2. Mondrian Partners Limited accumulated 755,018 shares or 1.89% of the stock. Bessemer Group Inc Incorporated has 0.01% invested in the company for 24,557 shares. Cleararc Cap accumulated 0.21% or 10,729 shares. Swiss Bancorp holds 0.21% of its portfolio in Monsanto Company (NYSE:MON) for 1.28 million shares. Davidson Advsr owns 175 shares or 0% of their US portfolio. Geneva Advsr Limited Company has 395,519 shares for 0.76% of their US portfolio. The Japan-based Meiji Yasuda Asset Management has invested 0.43% in Monsanto Company (NYSE:MON). Garland Cap Mgmt Inc holds 2.81% or 33,900 shares in its portfolio. Kidder Stephen W last reported 0.24% of its portfolio in the stock. Puplava Financial holds 1.57% of its portfolio in Monsanto Company (NYSE:MON) for 23,672 shares. Cheyne Capital (Uk) Llp holds 154,500 shares or 9.5% of its portfolio. Moreover, Eton Park Mngmt LP has 0.5% invested in Monsanto Company (NYSE:MON) for 281,634 shares. Prudential Public Limited Company, a Illinois-based fund reported 6,998 shares. Insight 2811 holds 0.89% of its portfolio in Monsanto Company (NYSE:MON) for 13,900 shares. First National Tru has 0.1% invested in the company for 6,554 shares.
Insider Transactions: Since October 10, 2016, the stock had 1 buy, and 3 selling transactions for $8.18 million net activity. $8.23 million worth of Monsanto Company (NYSE:MON) was sold by FRALEY ROBERT T on Thursday, October 13. On Tuesday, November 15 Preete Kerry J sold $277,145 worth of the stock or 2,745 shares. Another trade for 3,500 shares valued at $361,319 was made by MCMILLAN CHARLES S on Monday, October 10. MIZELL STEVEN sold 310 shares worth $31,958.
More notable recent Monsanto Company (NYSE:MON) news were published by: Seekingalpha.com which released: “Monsanto Holding Serve Ahead Of Regulatory Debates” on January 11, 2017, also Finance.Yahoo.com with their article: “Monsanto (MON) Upgraded to Buy on Solid Growth Drivers” published on January 11, 2017, Marketwatch.com published: “Agriculture company Monsanto reported improved first quarter earnings” on January 05, 2017. More interesting news about Monsanto Company (NYSE:MON) were released by: Seekingalpha.com and their article: “Monsanto’s Healthy Business Solidifies Bayer Deal Rationale” published on January 10, 2017 as well as Nasdaq.com‘s news article titled: “Monsanto Company (MON) Ex-Dividend Date Scheduled for January 04, 2017” with publication date: January 03, 2017.
According to Zacks Investment Research, “Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.”
Monsanto Company (NYSE:MON) Ratings Coverage
Out of 21 analysts covering Monsanto Company (NYSE:MON), 15 rate it a “Buy”, 0 “Sell”, while 6 “Hold”. This means 71% are positive. Monsanto Company has been the topic of 41 analyst reports since August 25, 2015 according to StockzIntelligence Inc. Citigroup maintained it with “Neutral” rating and $112 target price in Friday, July 1 report. The rating was maintained by Deutsche Bank on Thursday, September 15 with “Buy”. The rating was upgraded by Bernstein to “Mkt Perform” on Monday, September 26. The firm has “Neutral” rating given on Thursday, October 8 by JP Morgan. The rating was maintained by Argus Research with “Buy” on Friday, October 9. The stock of Monsanto Company (NYSE:MON) has “Equal-Weight” rating given on Thursday, October 6 by Barclays Capital. On Friday, August 19 the stock rating was maintained by Citigroup with “Neutral”. CLSA downgraded the stock to “Underperform” rating in Thursday, September 15 report. The firm earned “Underperform” rating on Friday, September 11 by Bernstein. Citigroup maintained it with “Neutral” rating and $116 target price in Monday, August 22 report.
MON Company Profile
Monsanto Company (Monsanto), incorporated on February 9, 2000, along with its subsidiaries, is a well-known provider of agricultural products for farmers. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.